Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis

Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis

(2013) Sonia Berrih-Aknin et al.   AUTOIMMUNITY REVIEWS

Altered expression of miR-146a in myasthenia gravis

(2013) Jiayin Lu et al.   NEUROSCIENCE LETTERS

Possible Involvement of Toll-Like Receptors in the Pathogenesis of Myasthenia Gravis

(2012) Yu-Zhong Wang et al.   INFLAMMATION

Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients

(2012) Kaleb M Pauley et al.   ARTHRITIS RESEARCH & THERAPY

Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity

(2011) Kaleb M. Pauley et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome

(2011) Erika Zilahi et al.   IMMUNOLOGY LETTERS

miR-146ais a significant brake on autoimmunity, myeloproliferation, and cancer in mice

(2011) Mark P. Boldin et al.   JOURNAL OF EXPERIMENTAL MEDICINE

BAFF serum levels in myasthenia gravis: effects of therapy

(2011) Flavia Scuderi et al.   JOURNAL OF NEUROLOGY

Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes

(2011) M. Balasubramanyam et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis

(2011) Anne Waschbisch et al.   PLoS One

A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus

(2011) Xiaobing Luo et al.   PLoS Genetics

Non-canonical NF-κB signaling pathway

(2010) Shao-Cong Sun   CELL RESEARCH

Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the VH and VK families

(2010) V. GUIGOU et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC

(2010) Neta S. Zuckerman et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

TLR4 Promotes B Cell Maturation: Independence and Cooperation with B Lymphocyte-Activating Factor

(2010) E. A. Hayashi et al.   JOURNAL OF IMMUNOLOGY

MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins

(2009) Yuanjia Tang et al.   ARTHRITIS AND RHEUMATISM

An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes

(2009) G. Curtale et al.   BLOOD

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

(2009) Matthew N Meriggioli et al.   LANCET NEUROLOGY

The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation

(2009) W.-L. Yang et al.   SCIENCE

A Potential Role for B-Cell Activating Factor in the Pathogenesis of Autoimmune Myasthenia Gravis

(2008) Samia Ragheb et al.   ARCHIVES OF NEUROLOGY

Role ofmiRNA-146ain the regulation of the innate immune response and cancer

(2008) Andrew E. Williams et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Serum BAFF expression in patients with myasthenia gravis

(2008) Jee Young Kim et al.   JOURNAL OF NEUROIMMUNOLOGY

Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells

(2008) D Bhaumik et al.   ONCOGENE

IRAK1: A critical signaling mediator of innate immunity

(2007) Sridevi Gottipati et al.   CELLULAR SIGNALLING

Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis

(2007) Xiang Li et al.   CLINICAL IMMUNOLOGY